These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 24880565)

  • 1. Endocrine aspects of bone metastases.
    Hofbauer LC; Rachner TD; Coleman RE; Jakob F
    Lancet Diabetes Endocrinol; 2014 Jun; 2(6):500-12. PubMed ID: 24880565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pathophysiology of bone metastases].
    Chappard D; Legrand E; Massin P; Basle MF; Audran M
    Prog Urol; 2003 Apr; 13(2 Suppl 1):9-17. PubMed ID: 12815804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D deficiency promotes growth of MCF-7 human breast cancer in a rodent model of osteosclerotic bone metastasis.
    Ooi LL; Zheng Y; Zhou H; Trivedi T; Conigrave AD; Seibel MJ; Dunstan CR
    Bone; 2010 Oct; 47(4):795-803. PubMed ID: 20638491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Wnts in prostate cancer bone metastases.
    Hall CL; Kang S; MacDougald OA; Keller ET
    J Cell Biochem; 2006 Mar; 97(4):661-72. PubMed ID: 16447163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone metastasis: histological changes and pathophysiological mechanisms in osteolytic or osteosclerotic localizations. A review.
    Chappard D; Bouvard B; Baslé MF; Legrand E; Audran M
    Morphologie; 2011 Jun; 95(309):65-75. PubMed ID: 21620753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of Vitamin D Deficiency in Patients with Bone Metastases and Multiple Myeloma.
    Maier GS; Horas K; Kurth AA; Lazovic D; Seeger JB; Maus U
    Anticancer Res; 2015 Nov; 35(11):6281-5. PubMed ID: 26504063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone metastases in breast cancer, prostate cancer and myeloma.
    Paterson AH
    Bone; 1987; 8 Suppl 1():S17-22. PubMed ID: 3318889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basic mechanisms responsible for osteolytic and osteoblastic bone metastases.
    Guise TA; Mohammad KS; Clines G; Stebbins EG; Wong DH; Higgins LS; Vessella R; Corey E; Padalecki S; Suva L; Chirgwin JM
    Clin Cancer Res; 2006 Oct; 12(20 Pt 2):6213s-6216s. PubMed ID: 17062703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computed microtomography of bone specimens for rapid analysis of bone changes associated with malignancy.
    Chappard D; Libouban H; Legrand E; Ifrah N; Masson C; Baslé MF; Audran M
    Anat Rec (Hoboken); 2010 Jul; 293(7):1125-33. PubMed ID: 20583257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms of tumor-bone interactions in osteolytic metastases.
    Chirgwin JM; Guise TA
    Crit Rev Eukaryot Gene Expr; 2000; 10(2):159-78. PubMed ID: 11186331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone.
    Clines GA; Guise TA
    Endocr Relat Cancer; 2005 Sep; 12(3):549-83. PubMed ID: 16172192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of tumor metastasis to the bone: challenges and opportunities.
    Reddi AH; Roodman D; Freeman C; Mohla S
    J Bone Miner Res; 2003 Feb; 18(2):190-4. PubMed ID: 12568395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Imaging of osteosclerotic metastases].
    Feydy A; Carlier R; Vallée C; Mompoint D; Chevallier A; Engerand S; Bhavsar P; Ollivier L
    J Radiol; 1995 Sep; 76(9):561-72. PubMed ID: 7473396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dickkopf-1 as a mediator and novel target in malignant bone disease.
    Rachner TD; Göbel A; Benad-Mehner P; Hofbauer LC; Rauner M
    Cancer Lett; 2014 May; 346(2):172-7. PubMed ID: 24462802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of osteolytic bone metastases in breast carcinoma.
    Käkönen SM; Mundy GR
    Cancer; 2003 Feb; 97(3 Suppl):834-9. PubMed ID: 12548583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate carcinoma skeletal metastases: cross-talk between tumor and bone.
    Keller ET; Zhang J; Cooper CR; Smith PC; McCauley LK; Pienta KJ; Taichman RS
    Cancer Metastasis Rev; 2001; 20(3-4):333-49. PubMed ID: 12085970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular biology of bone metastasis.
    Kingsley LA; Fournier PG; Chirgwin JM; Guise TA
    Mol Cancer Ther; 2007 Oct; 6(10):2609-17. PubMed ID: 17938257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences of osteoblastic bone metastases and osteolytic bone metastases in clinical features and molecular characteristics.
    Fang J; Xu Q
    Clin Transl Oncol; 2015 Mar; 17(3):173-9. PubMed ID: 25351174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A medieval case of metastasizing carcinoma with multiple osteosclerotic bone lesions.
    Tkocz I; Bierring F
    Am J Phys Anthropol; 1984 Dec; 65(4):373-80. PubMed ID: 6395693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Approval summary for zoledronic acid for treatment of multiple myeloma and cancer bone metastases.
    Ibrahim A; Scher N; Williams G; Sridhara R; Li N; Chen G; Leighton J; Booth B; Gobburu JV; Rahman A; Hsieh Y; Wood R; Vause D; Pazdur R
    Clin Cancer Res; 2003 Jul; 9(7):2394-9. PubMed ID: 12855610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.